Show simple item record

dc.contributor.authorNguyen, Nam
dc.contributor.authorJang, Siyoung
dc.contributor.authorVock, Jacqueline
dc.contributor.authorVinh-Hung, Vincent
dc.contributor.authorChi, Alexander
dc.contributor.authorVos, Paul
dc.contributor.authorPugh, Judith
dc.contributor.authorVo, Richard
dc.contributor.authorCeizyk, Misty
dc.contributor.authorDesai, Anand
dc.contributor.authorSmith-Raymond, Lexie
dc.contributor.authorthe International Geriatric, Radiotherapy Group
dc.date.accessioned2016-05-20T09:04:52Z
dc.date.available2016-05-20T09:04:52Z
dc.date.issued2014en
dc.identifier.citationNguyen et al. BMC Cancer 2014, 14:265 http://www.biomedcentral.com/1471-2407/14/265en
dc.identifier.doi10.1186/1471-2407-14-265en
dc.identifier.urihttp://hdl.handle.net/10150/610350
dc.description.abstractBACKGROUND:In this study the feasibility of intensity-modulated radiotherapy (IMRT) and tomotherapy-based image-guided radiotherapy (IGRT) for locally advanced esophageal cancer was assessed.METHODS:A retrospective study of ten patients with locally advanced esophageal cancer who underwent concurrent chemotherapy with IMRT (1) and IGRT (9) was conducted. The gross tumor volume was treated to a median dose of 70Gy (62.4-75Gy).RESULTS:At a median follow-up of 14months (1-39 months), three patients developed local failures, six patients developed distant metastases, and complications occurred in two patients (1 tracheoesophageal fistula, 1 esophageal stricture requiring repeated dilatations). No patients developed grade 3-4 pneumonitis or cardiac complications.CONCLUSIONS:IMRT and IGRT may be effective for the treatment of locally advanced esophageal cancer with acceptable complications.
dc.language.isoenen
dc.publisherBioMed Centralen
dc.relation.urlhttp://www.biomedcentral.com/1471-2407/14/265en
dc.rights© 2014 Nguyen et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).en
dc.rights.urihttps://creativecommons.org/licenses/by/2.0/
dc.subjectEsophageal canceren
dc.subjectTomotherapyen
dc.subjectNormal tissue sparingen
dc.titleFeasibility of intensity-modulated and image-guided radiotherapy for locally advanced esophageal canceren
dc.typeArticleen
dc.identifier.eissn 1471-2407en
dc.contributor.departmentDepartment of Radiation Oncology, Howard University Hospital, 2401 Georgia Avenue, N.W., Room 2055, Washington, DC 20060, USAen
dc.contributor.departmentDepartment of Radiation Oncology, Lindenhofspital, Bern, Switzerlanden
dc.contributor.departmentDepartment of Radiation Oncology, University Hospitals of Geneva, Geneva, Switzerlanden
dc.contributor.departmentDepartment of Radiation Oncology, University of West Virginia, Morgantown, WV, USAen
dc.contributor.departmentDepartment of Biostatistics, East Carolina University, Greenville, NC, USAen
dc.contributor.departmentDepartment of Pathology, University of Arizona, Tucson, AZ, USAen
dc.contributor.departmentDepartment of Pediatry, University of Virginia, Charlottesville, VA, USAen
dc.contributor.departmentDepartment of Radiation Oncology, Akron City Hospital, Akron, OH, USAen
dc.contributor.departmentDepartment of Radiation Oncology, University of Arizona, Tucson, AZ, USAen
dc.identifier.journalBMC Canceren
dc.description.collectioninformationThis item is part of the UA Faculty Publications collection. For more information this item or other items in the UA Campus Repository, contact the University of Arizona Libraries at repository@u.library.arizona.edu.en
dc.eprint.versionFinal published versionen
refterms.dateFOA2018-06-15T05:12:27Z
html.description.abstractBACKGROUND:In this study the feasibility of intensity-modulated radiotherapy (IMRT) and tomotherapy-based image-guided radiotherapy (IGRT) for locally advanced esophageal cancer was assessed.METHODS:A retrospective study of ten patients with locally advanced esophageal cancer who underwent concurrent chemotherapy with IMRT (1) and IGRT (9) was conducted. The gross tumor volume was treated to a median dose of 70Gy (62.4-75Gy).RESULTS:At a median follow-up of 14months (1-39 months), three patients developed local failures, six patients developed distant metastases, and complications occurred in two patients (1 tracheoesophageal fistula, 1 esophageal stricture requiring repeated dilatations). No patients developed grade 3-4 pneumonitis or cardiac complications.CONCLUSIONS:IMRT and IGRT may be effective for the treatment of locally advanced esophageal cancer with acceptable complications.


Files in this item

Thumbnail
Name:
1471-2407-14-265.pdf
Size:
1.814Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

© 2014 Nguyen et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).
Except where otherwise noted, this item's license is described as © 2014 Nguyen et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).